Nicholas Glover Insider Trading
Get free email notifications about insider trading for Nicholas Glover.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Nicholas Glover. Nicholas Glover is a Director in MEI Pharma, Inc. ($MEIP) and a CEO and President in ProNAi Therapeutics Inc ($DNAI).
Address: C/O MEI PHARMA, INC 11975 EL CAMINO REAL, SUITE 101 SAN DIEGO 92130 CA
Companies in which Nicholas Glover is an Insider
MEI Pharma, Inc.
Trading Symbol: MEIPIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Nicholas Glover: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Jul 07 2020
$MEIP Market Capitalization: $57.00M
$MEIP Previous Close: $1.55
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Sierra Oncology, Inc.
Trading Symbol: SRRAIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Nicholas Glover: CEO and President
Holdings: 0 shares
Latest Transaction: Mar 05 2019
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Nicholas Glover
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jul 07 2020 | MEIP | MEI Pharma, Inc. | Glover Nicholas | Director | Option Exercise | A | 3.49 | 50,000 | 174,500 | 50,000 | |
Jul 03 2019 | MEIP | MEI Pharma, Inc. | Glover Nicholas | Director | Option Exercise | A | 2.52 | 40,000 | 100,800 | 40,000 | |
Mar 05 2019 | SRRA | Sierra Oncology, I ... | Glover Nicholas | CEO and President | Option Exercise | A | 1.96 | 607,500 | 1,190,700 | 607,500 | |
Jul 16 2018 | MEIP | MEI Pharma, Inc. | Glover Nicholas | Director | Option Exercise | A | 4.28 | 40,000 | 171,200 | 40,000 | |
Mar 07 2018 | SRRA | Sierra Oncology, I ... | Glover Nicholas | CEO and President | Option Exercise | A | 2.36 | 562,780 | 1,328,161 | 562,780 | |
Jul 10 2017 | MEIP | MEI Pharma, Inc. | Glover Nicholas | Director | Option Exercise | A | 2.83 | 40,000 | 113,200 | 118,793 | |
Mar 08 2017 | SRRA | Sierra Oncology, I ... | Glover Nicholas | CEO and President | Option Exercise | A | 1.45 | 195,000 | 282,750 | 195,000 |